Spire Healthcare Group plc (LON:SPI - Get Free Report)'s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 244.79 ($3.20) and traded as low as GBX 225.22 ($2.94). Spire Healthcare Group shares last traded at GBX 228.50 ($2.98), with a volume of 232,547 shares trading hands.
Analyst Ratings Changes
Separately, Berenberg Bank reaffirmed a "buy" rating and set a GBX 300 ($3.92) price objective on shares of Spire Healthcare Group in a report on Tuesday, September 17th.
Check Out Our Latest Stock Analysis on SPI
Spire Healthcare Group Stock Performance
The company's 50-day simple moving average is GBX 241.94 and its 200 day simple moving average is GBX 244.79. The stock has a market cap of £922.73 million, a P/E ratio of 3,264.29, a PEG ratio of 1.06 and a beta of 0.96. The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 169.51.
Insider Buying and Selling
In other Spire Healthcare Group news, insider Justin Ash acquired 21,100 shares of Spire Healthcare Group stock in a transaction on Tuesday, September 17th. The stock was purchased at an average price of GBX 236 ($3.08) per share, for a total transaction of £49,796 ($65,024.81). 34.71% of the stock is currently owned by corporate insiders.
Spire Healthcare Group Company Profile
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Read More
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
